Dr. Kelly C. Lee

Psychiatry, MTM, Burnout and Suicide Prevention, Pharmacogenomics

lee's picture
Kelly C. Lee, Pharm.D., M.A.S., BCPP

Professor of Clinical Pharmacy
Associate Dean for Assessment and Accreditation
Skaggs School of Pharmacy and Pharmaceutical Sciences

(858) 822-3462
Research Summary

Dr. Lee’s specialty area is psychiatric pharmacy and she is a Board-Certified Psychiatric Pharmacist. She is currently the Residency Program Director of the PGY2 Psychiatric Pharmacy Residency at UC San Diego and is Chair of the Specialty Council for Psychiatric Pharmacy for Board of Pharmaceutical Specialties. Dr. Lee’s research program involves the effective utilization of psychotropic medications within diverse patient populations, establishing innovative psychiatric practice models and assessment and prevention of burnout and suicide among students and professionals.  She practices in the General Psychiatry clinic at UCSD with emphasis on mood and anxiety disorders and adult ADHD. She established the first pharmacist-run outpatient psychiatric clinic at UC San Diego and practices under a Collaborative PracticeShe has also served as the Director of the PharmGenEd™ Training for Health Professional Schools.

Dr. Lee served as an expert consultant to the California Department of Corrections and Rehabilitation, MedImpact HealthCare Systems, Inc., and California Mental Health Care Management Program. Dr. Lee has published in numerous peer- reviewed journals and textbooks and is currently an Editor for Pharmacotherapy Principles and Practice textbook. Dr. Lee is involved professionally in organizations such as American College of Clinical Pharmacy (ACCP), American Association of Colleges of Pharmacy (AACP), American Society of Health-System Pharmacists (ASHP) and College of Psychiatric and Neurologic Pharmacists (CPNP). 

Academic Achievements


B.S. in Biology (1996) UCLA; Pharm.D. (2000) UCSF; Master of Advanced Study in Clinical Research (M.A.S.) (2012) UCSD; ASHP- Accredited Residency in Pharmacy Practice and Fellowship in Behavioral Health Sciences (2000- 2003) UCSF; Board Certification in Psychiatric Pharmacy (re-certified 2018) (BCPP). 

Awards and Honors:

Awarded 2019-2020 Faculty of Year by Class of (2020); Received Award of Excellence in Scholarship in Experiential Education from American Association of Colleges of Pharmacy, (2020); Elected as Chair of Specialty Council for Psychiatric Pharmacy, Board of Pharmaceutical Specialties, (2019); Awarded Best Collaborative Scholarship Award from American Association of Colleges of Pharmacy Assessment Special Interest Group, (2019); Selected to Harvard Macy Institute: A Systems Approach to Assessment in Health Professions Education, (2018);  Selected to inaugural IPEC Interprofessional Deans Leadership Program, (2017); Fellow, ACCP (2011), Rho Chi Honor Society (2004); Phi Lambda Sigma Leadership Society (2000). 

Leadership Experience:

Associate Dean for Assessment and Accreditation (2014 – present); Director, PGY2 Residency in Psychiatric Pharmacy (2012 – present); Chair, Specialty Council for Psychiatric Pharmacy, Board of Pharmaceutical Specialties (2019-2020)     


  • Therapeutics (SPPS 212C, )
  • Pharmacogenomics (SPPS 219)
  • Special Topics in Psychiatry Elective (SPPS 286)
Key Contributions
  • Effective use of psychotropic medications among patients with severe mental illness.
  • Established Pharmacist-Psychiatrist Collaborative MTM, Adult ADHD and General Psychiatry clinics at UC San Diego.
  • Evaluate shared curriculum in applications of pharmacogenomics (PharmGenEd™).
Selected Publications
  • Lee KC, et al (2018) Factors associated with cultures of assessment at US schools and colleges of pharmacy. Currents in Pharmacy Teaching and Learning. https://doi.org/10.1016/j.cptl.2018.11.002
  • Davidson JE, Proudfoot J, Lee K, Zisook S., (2019).  Nurse Suicide in the United States: Analysis of the Center for Disease Control 2014 National Violent Death Reporting System Dataset. Archives of Psychiatric Nursing 33(5):16–21.

  • Makunts T, Alpatty S, Lee K, Atayee R, Abagyan R. (2019) Proton-pump inhibitor use is associated with broad spectrum of neurological adverse events including impaired hearing, vision, and memory." Accepted for publication in Scientific Reports

  • Hirsch JD, et al (2019) Patterns of Stress, Coping and Health-Related Quality of Life in Doctor of Pharmacy Students: A Five Year Cohort Study. Accepted for publication in American Journal of Pharmaceutical Education.

  • Awdishu L, et al (2019) Advancing Pharmacist Collaborative Care within Academic Health Systems. Accepted for publication in Pharmacy.

  • Mnatzaganian CL, Atayee RS, Namba JM, Brandl K, Lee KC. (2019) The effect of sleep quality, sleep components, and environmental sleep factors on core curriculum exam scores among pharmacy students. Currents in Pharmacy Teaching and Learning .

  • Hefazi E, Boggie D, Huynh T, Lee K. (2019) Influence of psychotropic medications on readmission rates of patients receiving a pharmacist discharge medication reconciliation. Accepted for publication in J Pharmacy Practice.

  • Lee KC, Fairman KA, El-Ibiary SY. (2019) Item analysis of emotional exhaustion in pharmacy practice faculty. Accepted for publication in Currents in Pharmacy Teaching and Learning.

  • Hefazi E, Lee KC. (2020) Association of appropriate lithium monitoring and clinical outcomes in an outpatient psychiatric setting. Psychiatry Research. https://doi.org/10.1016/j.psychres.2020.112764

  • Davidson JE, Proudfoot J, Lee K, Terterian G, Zisook S. (2020) A longitudinal analysis of nurse suicide in the United States (2005-2016) with recommendations for action. Worldviews on Evidence-Based Nursing 17(1):6-15.

Selected Recent Publications (view more)